Teva Pharmaceutical Industries reported $2.15B in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 44.1B 5B Jun/2026
Dr.Reddys Laboratories INR 41.78B 4.02B Jun/2026
Guangzhou Baiy CNY 4.73B 3.03B Mar/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Kalbe Farma IDR 3.66T 214.43B Mar/2026
Richter Gedeon HUF 143.37B 25.78B Sep/2025
Sh Fosun Pharma CNY 6.69B 1.9B Dec/2025
Sun Pharmaceuticals INR 117.59B 7.65B Mar/2026
Teva Pharmaceutical Industries USD 2.15B 45M Jun/2026